Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| ABBOTT LABORATORIESABT · Entity 2314 | Senior Vice President | February 16, 2007 | February 20, 2007 |
| COMMERCIAL METALS CoCMC · Entity 8783 | Director | October 01, 2026 | October 05, 2026 |
| TransDigm Group INCTDG · Entity 2991 | Director | September 18, 2026 | September 21, 2026 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
ABBOTT LABORATORIES
Report date February 16, 2007 · Filed February 20, 2007
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common shares without par valueSEC Table I · non-derivative | Direct | 93,329 |
Ending reported balance
After 2007-02-20 transaction · row 5
5 source rows · reconciled sequenceRow 1 · 2007-02-16 · Grant · Acquired 20,400 · Balance 85,489 F1: These shares represent performance vested restricted stock awards under the Abbott Laboratories 1996 Incentive Stock Program. The awards have a 5-year term, with no more than 1/3 of the award vesting in any one year upon Abbott reaching a minimum return on equity target. The awards include the right to have stock withheld for tax purposes. Row 2 · 2007-02-16 · Grant · Acquired 17,000 · Balance 102,489 F2: These shares represent a retention award of restricted stock under the Abbott Laboratories 1996 Incentive Stock Program. The awards generally vest on the third anniversary of their grant date and include the right to have stock withheld for tax purposes. Row 3 · 2007-02-17 · Tax withholding · Disposed 4,060 · Balance 98,429 Row 4 · 2007-02-18 · Tax withholding · Disposed 1,424 · Balance 97,005 Row 5 · 2007-02-20 · Tax withholding · Disposed 3,676 · Balance 93,329 |
| Option (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $52.54 · Expires 2017-02-15 | Direct | 83,000 |
Reported balance
After 2007-02-16 transaction · row 6
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 6 · 2007-02-16 · Grant · Acquired 83,000 · Balance 83,000 F3: Employee stock option granted pursuant to the Abbott Laboratories 1996 Incentive Stock Program in a transaction exempt from Section 16(b) under Rule 16b-3. The option becomes exercisable in annual increments of 27,667 on 02/16/2008, 27,667 on 02/16/2009 and 27,666 on 02/16/2010. |
Filing footnotes · ownership attribution and instrument terms
F1: These shares represent performance vested restricted stock awards under the Abbott Laboratories 1996 Incentive Stock Program. The awards have a 5-year term, with no more than 1/3 of the award vesting in any one year upon Abbott reaching a minimum return on equity target. The awards include the right to have stock withheld for tax purposes.
F2: These shares represent a retention award of restricted stock under the Abbott Laboratories 1996 Incentive Stock Program. The awards generally vest on the third anniversary of their grant date and include the right to have stock withheld for tax purposes.
F3: Employee stock option granted pursuant to the Abbott Laboratories 1996 Incentive Stock Program in a transaction exempt from Section 16(b) under Rule 16b-3. The option becomes exercisable in annual increments of 27,667 on 02/16/2008, 27,667 on 02/16/2009 and 27,666 on 02/16/2010.
COMMERCIAL METALS Co
Report date October 01, 2026 · Filed October 05, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 29,939 |
Reported balance
After 2026-10-01 transaction · row 1
1 source rowRow 1 · 2026-10-01 · Grant · Acquired 577 · Balance 29,939 F1: Represents shares issued, at the election of the reporting person, in lieu of the quarterly cash retainer for board and committee service. |
Filing footnotes · ownership attribution and instrument terms
F1: Represents shares issued, at the election of the reporting person, in lieu of the quarterly cash retainer for board and committee service.
TransDigm Group INC
Report date September 18, 2026 · Filed September 21, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 993 |
Reported balance
After 2026-09-18 transaction · row 1
1 source rowRow 1 · 2026-09-18 · Grant · Acquired 41 · Balance 993 F1: Receipt of stock in lieu of payment of semi-annual director fee, based on fair market value in accordance with the Director Share Plan. |
Filing footnotes · ownership attribution and instrument terms
F1: Receipt of stock in lieu of payment of semi-annual director fee, based on fair market value in accordance with the Director Share Plan.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| February 16, 2007 Filed Feb 20, 2007 22:58 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | GrantCommon shares without par value | 20,400 | $52.54 | $1,071,816.00 |
DisclosureSEC source: 0001104659-07-012366 · a4.xml · nonDerivative · entry 1 MCCULLOUGH GARY E · CIK 0001163212 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 85,489 F1 · kind: These shares represent performance vested restricted stock awards under the Abbott Laboratories 1996 Incentive Stock Program. The awards have a 5-year term, with no more than 1/3 of the award vesting in any one year upon Abbott reaching a minimum return on equity target. The awards include the right to have stock withheld for tax purposes. Read SEC document |
| December 31, 2006 Filed Jan 3, 2007 21:21 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | Tax withholdingCommon shares without par value | 7,315 | $48.75 | $356,569.68 |
DisclosureSEC source: 0001104659-07-000371 · a4.xml · nonDerivative · entry 1 MCCULLOUGH GARY E · CIK 0001163212 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 65,089 Read SEC document |
| February 21, 2006 Filed Feb 22, 2006 22:45 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | SaleCommon shares without par value | 310 | $43.80 | $13,578.00 |
DisclosureSEC source: 0001104659-06-011229 · a4.xml · nonDerivative · entry 3 MCCULLOUGH GARY E · CIK 0001163212 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 72,404 Read SEC document |
| February 18, 2006 Filed Feb 22, 2006 22:45 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | Tax withholdingCommon shares without par value | 1,115 | $44.15 | $49,227.25 |
DisclosureSEC source: 0001104659-06-011229 · a4.xml · nonDerivative · entry 2 MCCULLOUGH GARY E · CIK 0001163212 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 72,714 Read SEC document |
| February 17, 2006 Filed Feb 22, 2006 22:45 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | GrantOption (right to buy) · Derivative | 83,000 | $0.00 Strike: $44.16 | $0.00 |
DisclosureSEC source: 0001104659-06-011229 · a4.xml · derivative · entry 4 MCCULLOUGH GARY E · CIK 0001163212 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 83,000 Underlying: common shares · 83,000 shares Expires 2016-02-16 F2 · security: Employee stock option granted pursuant to the Abbott Laboratories 1996 Incentive Stock Program in a transaction exempt from Section 16(b) under Rule 16b-3. The option becomes exercisable in annual increments of 27,667 on 2/17/2007, 27,667 on 2/17/08, and 27,666 on 2/17/09. Read SEC document |
| February 17, 2006 Filed Feb 22, 2006 22:45 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | GrantCommon shares without par value | 26,500 | $44.16 | $1,170,240.00 |
DisclosureSEC source: 0001104659-06-011229 · a4.xml · nonDerivative · entry 1 MCCULLOUGH GARY E · CIK 0001163212 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 73,829 F1 · kind: These shares represent performance vested restricted stock awards under the Abbott Laboratories 1996 Incentive Stock Program in a transaction exempt from Section 16(b) under Rule 16b-3. The awards have a 5 year term, with no more than 1/3 of the award vesting in any one year upon Abbott reaching a minimum return on equity target. The awards include the right to have stock withheld for tax purposes. Read SEC document |
| February 18, 2005 Filed Feb 23, 2005 22:51 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | GrantOption (right to buy) · Derivative | 63,800 | $0.00 Strike: $46.34 | $0.00 |
DisclosureSEC source: 0001104659-05-008017 · a4.xml · derivative · entry 2 MCCULLOUGH GARY E · CIK 0001163212 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 63,800 Underlying: common shares · 63,800 shares Expires 2015-02-17 F2 · security: Employee stock option granted pursuant to the Abbott Laboratories 1996 Incentive Stock Program in a transaction exempt from Section 16(b) under Rule 16b-3. The option becomes exercisable in annual increments of 21,267 on 2/18/06, 21,267 on 2/18/07 and 21,266 on 2/18/08. Read SEC document |
| February 18, 2005 Filed Feb 23, 2005 22:51 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | GrantCommon shares without par value | 9,300 | $46.34 | $430,962.00 |
DisclosureSEC source: 0001104659-05-008017 · a4.xml · nonDerivative · entry 1 MCCULLOUGH GARY E · CIK 0001163212 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 47,329 F1 · kind: These shares represent a restricted stock award under the Abbott Laboratories 1996 Incentive Stock Program in a transaction exempt from Section 16(b) under Rule 16b-3. The award includes the right to have stock withheld for tax purposes. Read SEC document |
| January 01, 2005 Filed Jan 4, 2005 19:29 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | Tax withholdingCommon shares without par value | 9,971 | $46.60 | $464,648.60 |
DisclosureSEC source: 0001104659-05-000221 · a4.xml · nonDerivative · entry 1 MCCULLOUGH GARY E · CIK 0001163212 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 38,029 Read SEC document |
| February 20, 2004 Filed Feb 24, 2004 21:14 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | GrantOption (right to buy · Derivative | 55,000 | $0.00 Strike: $43.66 | $0.00 |
DisclosureSEC source: 0001104659-04-005601 · a4.xml · derivative · entry 2 MCCULLOUGH GARY E · CIK 0001163212 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 55,000 Underlying: common shares · 55,000 shares Expires 2014-02-19 F2 · security: Employee stock option granted pursuant to the Abbott Laboratories 1996 Incentive Stock Program, including a replacement option feature, in a transaction exempt from Section 16(b) under Rule 16b-3. The option becomes exercisable in annual increments of 18,334 on 2/20/05, 18,333 on 2/20/06 and 18,333 on 2/20/07. Read SEC document |
| February 20, 2004 Filed Feb 24, 2004 21:14 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | GrantCommon shares without par value | 8,000 | $43.66 | $349,280.00 |
DisclosureSEC source: 0001104659-04-005601 · a4.xml · nonDerivative · entry 1 MCCULLOUGH GARY E · CIK 0001163212 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 48,000 F1 · kind: These shares represent a restricted stock award under the Abbott Laboratories 1996 Incentive Stock Program in a transaction exempt from Section 16(b) under Rule 16b-3. The award includes the right to have stock withheld for tax purposes. Read SEC document |
| December 31, 2003 Filed Jan 2, 2004 16:35 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | GrantOption (right to buy) · Derivative | 100,000 | $0.00 Strike: $46.62 | $0.00 |
DisclosureSEC source: 0001104659-04-000013 · a4.xml · derivative · entry 2 MCCULLOUGH GARY E · CIK 0001163212 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 100,000 Underlying: Common shares · 100,000 shares Expires 2013-12-30 F2 · security: Employee stock options granted pursuant to the Abbott Laboratories 1996 Incentive Stock Program, including a replacement option feature, in a transaction exempt from Section 16(b) under Rule 16b-3. The option becomes exercisable in annual increments of 33,334, 33,333, and 33,333 beginning on December 31, 2004, the first anniversary date of the grant. Read SEC document |
| December 31, 2003 Filed Jan 2, 2004 16:35 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | GrantCommon shares without par value | 40,000 | $46.62 | $1,864,800.00 |
DisclosureSEC source: 0001104659-04-000013 · a4.xml · nonDerivative · entry 1 MCCULLOUGH GARY E · CIK 0001163212 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 40,000 F1 · kind: These shares represent a restricted stock award under the Abbott Laboratories 1996 Incentive Stock Program in a transaction exempt from Section 16 under Rule 16b-3. The award includes the right to have stock withheld for tax purposes. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.